XML 36 R26.htm IDEA: XBRL DOCUMENT v3.22.1
Supplementary Balance Sheet Information - Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2022
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Accrued compensation $ 878 $ 1,435
Preferred stock dividend 420 414
Clinical trials 2,110 1,639
Research agreements and services 992 726
Director fees 141 141
Professional fees and outside services 53 63
Patent, license and other fees 75 43
Other accrued liabilities 69 66
Total accrued liabilities $ 4,738 $ 4,527